Ekso Bionics Holding ( (EKSO) ) has released its Q3 earnings. Here is a breakdown of the information Ekso Bionics Holding presented to its investors.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Ekso Bionics Holdings, Inc., based in San Rafael, California, is a pioneering company in exoskeleton technology, focusing on enhancing human capabilities in both medical and industrial sectors. In its third-quarter 2025 financial report, Ekso Bionics highlighted a notable recovery with a 2% year-over-year revenue growth and a significant 105% increase from the previous quarter, reaching $4.2 million. The company also reported an improved gross margin of 60.3% and a reduced net loss of $1.4 million, marking a 31% improvement from the previous year. Key financial metrics showed a decrease in operating expenses, driven by lower payroll costs due to the Employee Retention Credit, and a strategic focus on high-margin sales. Additionally, Ekso Bionics launched ‘eksoUniversity’, enhancing its educational outreach. Looking ahead, the company is exploring strategic transactions to potentially diversify its business, while continuing to execute its growth strategy. The management remains optimistic about navigating future challenges and opportunities.